Peri-implant Disease and Chronic Periodontitis: Is Interleukin-6 Gene Promoter Polymorphism the Common Risk Factor in a Brazilian Population?

The International journal of oral & maxillofacial implants (Impact Factor: 1.45). 02/2013; 28(1):35-43. DOI: 10.11607/jomi.2867
Source: PubMed


To investigate the association between interleukin-6 (IL-6) G174C polymorphism and susceptibility to peri-implant disease (PID) and/or chronic periodontitis (CP), in Brazilian subjects.

Materials and methods:
A total of 103 Brazilian patients were submitted to peri-implant and periodontal examination. According to their peri-implant characteristics, patients were divided into: group A (healthy, n = 52), group B (peri-implant mucositis, n = 20), and group C (peri-implantitis, n = 31). All patients (n = 103) were also characterized as healthy periodontium patients without CP (HP, n = 60) or CP patients (CP, n = 43). DNA was extracted from buccal cells, and the IL-6 G174C polymorphism was genotyped by polymerase chain reaction-restriction fragment length polymorphism. Differences in the prevalence of genotypes and alleles between healthy and ill patients were analyzed by chi-square test (P < .05), considering PID, CP, and PID+CP.

Results considered the presence of PID and/or CP in all patients. The CC genotype was the least common in all groups. The chi-square test showed no significant correlation between genotypes. However, the odds ratio showed that individuals with GG genotype and allele G were 1.53 and 1.43 times more susceptible to PID, respectively. The risk of presenting CP was increased in patients with GG genotype and allele G 1.35 and 1.24 times, respectively. When both diseases were evaluated together, patients with GG genotypes and allele G were 1.75 and 1.50 times more likely to present PID and CP together. When PID was evaluated without CP, patients with allele G were 2.08 times more susceptible to PID.

The frequency of the genotype IL-6 174GG and allele G was different between healthy and ill groups. Therefore, this genotype may be a common risk factor for both CP and PID in Brazilian populations.

17 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background To develop preventive strategies addressing peri-implant diseases, a thorough understanding of the epidemiology is required.AimThe aim was to systematically assess the scientific literature in order to evaluate the prevalence, extent and severity of peri-implant diseases.Material & Methods Data were extracted from identified studies. Meta-analyses for prevalence of peri-implant mucositis and peri-implantitis were performed. The effect of function time and disease definition on the prevalence of peri-implantitis was evaluated by meta-regression analyses. Data on extent and severity of peri-implant diseases was estimated if not directly reported.Results15 articles describing 11 studies were included. Case definitions for mucositis and peri-implantitis varied. The prevalence of peri-implant mucositis and peri-implantitis ranged from 19-65% and from 1-47%, respectively. Meta-analyses estimated weighted mean prevalences of peri-implant mucositis and peri-implantitis of 43% (CI: 32-54%) and 22% (CI: 14-30%), respectively. The meta-regression showed a positive relationship between prevalence of peri-implantitis and function time and a negative relationship between prevalence of peri-implantitis and threshold for bone loss. Extent and severity of peri-implant diseases were rarely reported.Conclusion Future studies on the epidemiology of peri-implant diseases should consider (i) applying consistent case definitions and (ii) assessing random patient samples of adequate size and function time.This article is protected by copyright. All rights reserved.
    Journal Of Clinical Periodontology 12/2014; 42(S16). DOI:10.1111/jcpe.12334 · 4.01 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This narrative review focuses on the current understanding of the definition and prevalence of peri-implantitis. A MEDLINE (PubMed) search over the past 3 years was performed using keywords related to the definition and prevalence of peri-implantitis. Additional literature retrieved from reference lists, review articles, and consensus reports were used. Definition of peri-implantitis is heterogeneous due to the various thresholds of bone loss and pocket depths used, creating a discrepancy in the prevalence figures. The prevalence of peri-implant mucositis varied between 19 and 65 %, whereas the prevalence of peri-implantitis ranged from 10 to 40 %. A consensus has been reached that the definition of peri-implantitis should be clinical signs of inflammation (bleeding on probing) and/or suppuration, in combination with progressive bone loss. In addition, we strongly recommend that measurement of the bone loss in relation to the implant length would further classify the case as mild, moderate, or severe peri-implantitis.
    12/2014; 1(4). DOI:10.1007/s40496-014-0031-x
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dental implants are an important treatment option for patients interested in replacing lost or missing teeth. Although a robust body of literature has reviewed risk factors for tooth loss, the evidence for risk factors associated with dental implants is less well defined. This article focuses on key systemic risk factors relating to dental implant failure, as well as on perimucositis and peri-implantitis. Copyright © 2015 Elsevier Inc. All rights reserved.
    Dental Clinics of North America 12/2014; 59(1). DOI:10.1016/j.cden.2014.09.002
Show more